当前位置：首页 > 文献互助 > 互助详情

Safety of low lipoprotein(a) levels: the FOURIER trial复制

用户k7g3AjDeE8DM 53分钟前 8 10 求助中 帖子自动结束时间: 2026-07-05 14:12:08

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1093/eurheartj/ehag398复制

文献链接: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag398/8700770复制

其他信息:

出版社: Oxford University Press (OUP)
作者: Baris Gencer; Robert P Giugliano; Xinhui Ran; François Mach; Erik S G Stroes; Ioanna Gouni-Berthold; Richard Češka; Marat V Ezhov; J Wouter Jukema; Henrik K Jensen; S Lale Tokgözoğlu; Kurt Huber; KyungAh Im; Marc S Sabatine; Michelle L O’Donoghue
全文下载地址: https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehag398/68461371/ehag398.pdf

上一篇：Are we underestimating the benefits of lipid-lowering therapies?

下一篇：Interleukin-6 as a Biomarker and Treatment Target for Atherosclerotic Disease

互助时间线

2026-06-30 14:12:08 [发起求助]

最新发布的求助

Microglial mitochondria transfer to astrocytes via GPNMB-enriched extracellular vesicles alleviates cognitive deficits in tauopathy mice 33秒前
Contribution of Nontarget Cells to the Disposition, Antitumor Activity, and Antigen-Independent Toxicity of Antibody–Drug Conjugates 7分钟前
The GLP-1 Ceiling and GIP Dividend 11分钟前
On the Noninferiority of Tirzepatide 12分钟前
Obesity, Adipose Biology, and the Next Frontier in Cardiovascular Medicine 39分钟前
Screening and Treatment Using a Risk-Based Approach with NT-proBNP Guidance in Diabetes Mellitus 43分钟前
The Expanding Oral Options for LDL Cholesterol Management 47分钟前
Interleukin-6 as a Biomarker and Treatment Target for Atherosclerotic Disease 49分钟前
Safety of low lipoprotein(a) levels: the FOURIER trial 53分钟前
Are we underestimating the benefits of lipid-lowering therapies? 57分钟前
Novel highly stereospecific method of 1,2- -glycosylation. Synthesis of α-D-glucosyl-D-glucoses 1小时前
Practice for Demonstrating Capability to Comply with an Acceptance Procedure 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com